PGNY
Progyny, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$25.94
−2.52%Aug 15, 2026, 03:49 UTC
Progyny reported Q2 CY2026 revenue of $350.5 million and adjusted EPS of $0.55, beating analyst estimates, but the stock fell in reaction.
Source:Aug 11, 2026, 23:59 UTC
Progyny Inc's stock fell 4.6% to $26.55 on August 11, 2026.
Source:Aug 6, 2026, 21:55 UTC
Progyny reported Q2 2026 adjusted earnings of $0.55 per share on revenue of $350.51 million, beating analyst estimates of $0.34 and $348.69 million, respectively.